Probenecid | Interleukin Related interleukin-related.com

Product Name :
Probenecid

Search keywords :
Cytochrome P450 2C9

drugId :
null

Target Vo:
Cytochrome P450 2C9

Target Vo Short Name :
CYP2C9

Moa_Name:
Cytochrome P450 2C9 inhibitors

First Approval Country :
United States

First Approval Date Filter:
1951

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :
Brown University

Active Indication_Name:
Gout

In Active Indication_Name:
Hyperuricemia

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MMAE Antibody (YA899) References
Lonigutamab Epigenetics
ERK2 Antibody: ERK2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to ERK2. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts